Media Contact:
Katrina Norfleet
Posted: 5/5/2014

First reversible glue bandage could save injured soldiers’ vision

Orlando, Fla. — Scientists have developed the first reversible glue that could be used on the battlefield to treat eye injuries, potentially saving soldiers’ vision. The research is being presented at the 2014 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Orlando, Fla.

When applied to a wounded eye, the adhesive warms up and becomes sticky, sealing the wound and minimizing further damage while the soldier is transported for treatment. Upon arriving at a hospital, doctors can simply apply cool saline solution to the glue, causing it to revert to its non-adhesive form and be removed with minimal discomfort.

Improvised explosive devices (IEDs) have increased the frequency of military-related eye injuries to 16% of all injuries reported. Once the eye is punctured, loss of internal fluids can lead to retinal detachment and vision loss if not prevented.

Abstract Title: Thermoresponsive Reversible Adhesive for Temporary Intervention in Ocular Trauma
Presentation Start/End Time: Monday, May 5, 3:45 – 5:30pm
Location: Exhibit/Poster Hall SA
Session Number: 277

# # #

The  Association for Research in Vision and Ophthalmology (ARVO)  is the largest eye and vision research organization in the world. Members include nearly 12,000 eye and vision researchers from over 75 countries. ARVO advances research worldwide into understanding the visual system and preventing, treating and curing its disorders. 

All abstracts accepted for presentation at the ARVO Annual Meeting represent previously unpublished data and conclusions. This research may be proprietary or may have been submitted for journal publication. Embargo policy: Journalists must seek approval from the presenter(s) before reporting data from paper or poster presentations. Press releases or stories on information presented at the ARVO Annual Meeting may not be released or published until the conclusion of the presentation.


Visit us at:

SFN-Nov 8